Injectable contraceptives are an increasingly popular method of family planning. They are safe, discrete, highly effective, and generally last for several months. Sayana® Press, also known as subcutaneous depot medroxyprogesterone (DMPA‑SC), is a lower‑dose formula version of the already popular injectable Depo‑Provera. DMPA‑SC combines the drug and needle in a single‑use unit, which makes it easy to transport and simple to use with little training. DMPA‑SC can be administered by community health workers (CHWs) and women themselves – potentially making injectable contraceptives available to women who can’t easily travel to clinics.

Emergency contraception (EC) refers to any contraceptive method that can be used after having unprotected or inadequately protected sexual intercourse (UPSI) but before pregnancy occurs, providing women with the opportunity to prevent an unwanted pregnancy. EC is a safe and effective method for preventing unwanted pregnancy and can reduce the risk of pregnancy by up to 99%. In spite of its effectiveness, EC is not frequently used. In many countries, women face barriers to accessing EC. The majority of women in low‑income countries are unaware of EC. Moreover, some providers have negative attitudes toward providing EC to women and girls.

The Global Financing Facility (GFF) is a financing mechanism in support of reproductive, maternal, newborn, child and adolescent health launched in 2015. This IPPF briefing sets out recommendations for GFF stakeholders and financiers as the GFF undergoes its first replenishment process.

The way abortion is presented in the media can have a major influence on a person's opinion on abortion. This guide has been written for those working in the media to encourage accurate reporting of the facts about abortion, and honest portrayals of abortion as part of real people’s lives and relationships. Produced in collaboration with the International Campaign for Women’s Right to Safe Abortion.  

The Global Sexual and Reproductive Health Service Package for Men and Adolescent Boys has been developed to support providers of sexual and reproductive health services. It aims to increase the range and quality of sexual and reproductive services provided that meet the specific and diverse needs of men and adolescents boys. It covers men and adolescent boys in all their diversity, and takes a positive approach to sexual and reproductive health, seeing this not just as the absence of disease, but the positive expression of one’s gender, sex and sexuality. Men have substantial sexual and reproductive health needs, including the need for contraception, prevention and treatment of HIV and other sexually transmitted infections (STIs), sexual dysfunction, infertility and male cancers. Yet these needs are often unfulfilled due to a combination of factors, including a lack of service availability, poor health-seeking behaviour among men, health facilities often not considered "male-friendly," and a lack of agreed standards for delivering clinical and preventative services to men and adolescent boys. 

IPPF recognizes that investing in gender equality is essential both as a means for fulfilling SRHR and as an end in itself. Sexual and reproductive health and rights will only be achieved when there is gender equality.  The report is available in English, French, Spanish and Arabic.